The partial left-sided ventrical resection in dilatative cardiomyopathy is aimed at improving the ejection efficiency of the heart by reducing the ventricular volume. In the meantime, reduction ventriculoplasty has been used worldwide as an alternative to heart transplantation in a multitude of patients with dilatative cardiomyopathy. The intraoperative death rate ranges from 5 to 10%, and the one year survival rate of the patients ranges from 85 to 90%. One year postoperatively, 70-80% of patients are in NYHA class I.